Matropin is an ideal mydriatic and cycloplegic agent in ophthalmology.
Matropin Eye Drops: Each ml contains Homatropine Hydrobromide USP 20 mg.
Matropin Eye Drops is indicated for use as a mydriatic and cycloplegic ag
For refraction: Instill two drops in the eye(s) and repeat 2-3 times at 5-10 minute intervals. For therapy: Instill 1-2 drops in the eye(s) every 3-4 hours.
Contraindicated in patients with closed-angle glaucoma or with a narrow angle between the iris and the cornea.
Should be used with caution in patients with prostatic enlargement and in patients suffering from paralytic ileus or pyloric stenosis.
Hypersensitivity may occur as conjunctivitis.
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Matropin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in lactation: It is not known whether Homatropine is excreted in human milk. Caution should be exercised when Matropin is administered to a nursing mother.
Use in children: Should not be used in children below the age of 3 months.
Matropin Eye Drops: Each LDPE dropper bottle contains 10 ml sterile eye drops.
FR
DE
